Cognitive Behavioral Therapy for Chronic Insomnia
Trial Summary
What is the purpose of this trial?
This project is a single center, prospective randomized controlled trial (N=198) primarily evaluating the efficacy of the Survivorship Sleep Program vs. Enhanced Usual Care on insomnia severity among cancer survivors. The investigators will also examine secondary outcomes associated with cancer-related insomnia including subjective and objective sleep measures (i.e., sleep diaries, actigraphy), emotional distress, fatigue, and use of sleep medications. Notably, most CBT-I trials with cancer survivors who have completed primary treatment with curative intent (i.e., curvivors) but not those in treatment or living with metastatic cancer (i.e., metavivors). To enhance generalizability, this RCT will stratify enrollment by survivorship phase (1:1:1). This project in strengthened by partnerships with community organizations (SurvivorJourneys and Ellie Fund) and use of both quantitative (i.e., surveys, actigraphy) and qualitative methods (i.e., interviews) to inform considerations for future implementation. Collectively, the proposed project will yield multiple deliverables to innovate cancer survivorship care, namely an efficacious, virtually delivered intervention addressing chronic insomnia, one of the most deleterious concerns among the growing population of cancer survivors in the US. Findings will inform a future effectiveness trial and the expansion of the synchronous delivery of CBT-I to survivors across different phases of cancer survivorship.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it does allow the use of hormonal, maintenance, oral, and immunotherapies.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Insomnia?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBT-I) is effective in improving sleep for people with insomnia, including those with other health issues. Studies found that CBT-I helps reduce the time it takes to fall asleep, decreases night awakenings, and improves overall sleep quality, with benefits lasting at least a month.12345
Is Cognitive Behavioral Therapy for Insomnia safe for humans?
How is Cognitive Behavioral Therapy for Insomnia different from other treatments for chronic insomnia?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is unique because it focuses on changing unhelpful sleep habits and beliefs through structured sessions, rather than using medication. It includes techniques like sleep restriction, stimulus control, and cognitive restructuring, which help create lasting improvements in sleep patterns.1112131415
Eligibility Criteria
This trial is for cancer survivors suffering from chronic insomnia, regardless of their phase in survivorship. It includes those who've completed primary treatment and those with metastatic cancer. Participants must be willing to engage in virtual therapy sessions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Survivorship Sleep Program (SSP) or Enhanced Usual Care (EUC) over 6 weeks, including 4 weekly virtual sessions and 1 booster session
Follow-up
Participants are monitored for changes in insomnia severity and secondary outcomes such as sleep efficiency, emotional distress, and fatigue
Treatment Details
Interventions
- Cognitive Behavioral Therapy - Insomnia
- Enhanced Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
American Cancer Society, Inc.
Collaborator